p27Kip1 in Stage III Colon Cancer: Implications for Outcome Following Adjuvant Chemotherapy in CALGB 89803
      QxMD      Google Scholar   
Citation:
Clin Cancer Res vol 15 2116-2122
Year:
2009
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA047577, U10 CA032291, CA33601, U10 CA071323, CA77597, U10 CA077658, CA47577, CA32291, CA29165, U10 CA045564, U10 CA035279, U10 CA045808, U10 CA031946, U10 CA033601, U10 CA077597, U10 CA035421, U10 CA114558, U10 CA045418, U10 CA077440, U10 CA037447, U10 CA041287, U10 CA037447-27, U10 CA047559, U10 CA077651, CA04326, CA71323, CA45418, U10 CA074811, U10 CA047642, CA31946, U10 CA003927  
Corr. Author:
 
Authors:
                           
Primary Study
Secondary Studies:
C89803, C150705
Phases:
, 3
Keywords:
Colorectal cancer, adjuvant therapy, biomarkers